Shanghai Xiao Fang Pharmaceutical Co.,Ltd. (SHA:603207)
China
· Delayed Price · Currency is CNY 26.25
+0.01 (0.04%)
At close: Apr 30, 2026
SHA:603207 Market Cap
SHA:603207 has a market cap or net worth of 4.22 billion as of April 30, 2026. Its market cap has decreased by -12.20% in one year.
Market Cap
4.22B
Enterprise Value
3.58B
Revenue
504.59M
Ranking
n/a
PE Ratio
19.76
Stock Price
26.25
Market Cap Chart
Since August 26, 2024, SHA:603207's market cap has decreased from 5.33B to 4.22B, a decrease of -20.80%. That is a compound annual growth rate of -13.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 4.22B | -8.17% |
| Dec 31, 2025 | 4.60B | 2.24% |
| Dec 31, 2024 | 4.49B | -15.65% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LanZhou Foci Pharmaceutical | 4.20B |
| Sinotherapeutics | 4.11B |
| Shandong Wohua Pharmaceutical | 4.35B |
| Shanghai Jiaoda Onlly Co.,Ltd | 4.01B |
| Zhuhai Rundu Pharmaceutical | 4.45B |
| Jinhe Biotechnology CO., LTD. | 4.51B |
| Newland Pharmaceutical | 4.52B |
| Guizhou Sanli Pharmaceutical Co.,Ltd | 4.52B |